These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6193442)

  • 1. [Cloning of mouse glioma-specific killer T cells].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    Neurol Med Chir (Tokyo); 1983 Mar; 23(3):181-3. PubMed ID: 6193442
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antitumor efficacy of lymphokine-activated killer (LAK) cells and gamma interferon production induced in vitro from peripheral blood lymphocytes of patients with malignant gliomas].
    Shimizu K; Miyao Y; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H; Nanjo M; Ishida N
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):760-6. PubMed ID: 3093611
    [No Abstract]   [Full Text] [Related]  

  • 3. Establishment of experimental malignant glioma-specific cytotoxic T lymphocyte clone by T cell growth factor.
    Yamasaki T; Handa H; Yamashita J; Namba Y; Watanabe Y; Kuwata S; Hanaoka M
    J Neurosurg; 1984 May; 60(5):998-1004. PubMed ID: 6201598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of anti-tumor cell-mediated immunity by local irradiation against transplanted brain tumor (author's transl)].
    Suda K
    Nihon Geka Hokan; 1982 Jan; 51(1):59-69. PubMed ID: 6979988
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the peculiarity of immunological responses to experimental brain tumor].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1983 Mar; 35(3):229-36. PubMed ID: 6602617
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Taguchi M; Kuwata S; Namba Y; Hanaoka M
    J Neurosurg; 1985 Nov; 63(5):763-70. PubMed ID: 3932609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new experimental approach to the specific adoptive immunotherapy for malignant gliomas].
    Yamasaki T
    Nihon Geka Hokan; 1983 Nov; 52(6):783-801. PubMed ID: 6331809
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro and in vivo demonstration of specific killer T lymphocytes to transplanted glioma (author's transl)].
    Nakao S; Namba Y; Hanaoka M; Yamashita J; Oda Y; Handa J
    Neurol Med Chir (Tokyo); 1978 Jul; 18(5 Pt 2):393-400. PubMed ID: 80762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma immunomodulatory effect of interferons on tumor-associated antigen].
    Miyatake S
    Nihon Geka Hokan; 1988 Jan; 57(1):55-68. PubMed ID: 3138955
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human interleukin 2].
    Chouaib S; Fradelizi D
    Ann Immunol (Paris); 1983; 134D(2):157-65. PubMed ID: 6419669
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of specific immunization with virus-infected glioma cells against intracerebrally implanted glioma (author's transl)].
    Yumitori K
    Nihon Geka Hokan; 1980 Nov; 49(6):774-82. PubMed ID: 7283598
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of survival of mice with glioma treated with semiallogeneic fibroblasts secreting interleukin-2.
    Glick RP; Lichtor T; de Zoeten E; Deshmukh P; Cohen EP
    Neurosurgery; 1999 Oct; 45(4):867-74. PubMed ID: 10515482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of interleukin-2 in immune surveillance against brain tumors.
    Yoshida S; Takai N; Tanaka R
    Neurosurgery; 1987 Nov; 21(5):627-30. PubMed ID: 3501073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cell-mediated immunity of experimental brain tumors].
    Kiya K; Okamoto H; Harada K; Uozumi T; Toge T; Hattori T
    Neurol Med Chir (Tokyo); 1983 Feb; 23(2):109-15. PubMed ID: 6191229
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristic immunological responses to an experimental mouse brain tumor.
    Yamasaki T; Handa H; Yamashita J; Namba Y; Hanaoka M
    Cancer Res; 1983 Oct; 43(10):4610-7. PubMed ID: 6603902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Partial characterization of surface tumor associated antigens of established murine glioma cell line (203-glioma) (author's transl)].
    Nakao S
    No To Shinkei; 1979 Jan; 31(1):95-103. PubMed ID: 426937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immune response in rats immunized with chemically modified syngeneic glioma cells. Monitoring by in vivo parameters and in vitro immune cytolysis.
    Bilzer T; Stavrou D; Dahme E; Anzil AP
    Anticancer Res; 1982; 2(6):345-54. PubMed ID: 6984814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.